Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials.

Source:http://linkedlifedata.com/resource/pubmed/id/9065919

Download in:

View as

General Info

PMID
9065919